08156.HK
Sinopharm Tech Holdings Limited
HKSE · Technology · Software - Application · HK
HKD 0.18
+0.00%Year over year
Reported trailing growth
- Revenue
- -44.7%
- EBITDA
- —
- EBIT
- +100.0%
- EPS
- -99.8%
- Free cash flow
- -23.9%
- Operating cash flow
- +13.4%
Forward estimates
Based on analyst estimates
- Revenue
- —
- EBITDA
- —
- EPS
- —
Three-year CAGR
- Revenue
- +2.1%
- EBITDA
- —
- EBIT
- -14.6%
- Net income
- —
- EPS
- —
- Free cash flow
- +44.2%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Jun 1, 2026